Dinsmore Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.36M Hold
25,000
0.59% 79
2015
Q2
$1.68M Hold
25,000
0.66% 68
2015
Q1
$1.46M Hold
25,000
0.57% 82
2014
Q4
$1.64M Hold
25,000
0.64% 65
2014
Q3
$1.46M Hold
25,000
0.58% 74
2014
Q2
$1.41M Hold
25,000
0.54% 82
2014
Q1
$1.28M Hold
25,000
0.51% 88
2013
Q4
$1.32M Buy
25,000
+5,000
+25% +$246K 0.54% 82
2013
Q3
$895K Hold
20,000
0.37% 115
2013
Q2
$827K Buy
+20,000
New +$875K 0.36% 110

Other funds holding ABBV

Dinsmore Capital Management's ABBV Position: Q3 2015 in Review

Dinsmore Capital Management held its AbbVie (ABBV) position steady in Q3 2015 at 25,000 shares worth $1.36M. The position accounts for 0.59% of the portfolio, ranked #79.

Dinsmore Capital Management first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.68M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Dinsmore Capital Management held 25,000 shares of AbbVie worth $1.36M as of Q3 2015.
  • Dinsmore Capital Management left its AbbVie share count unchanged in Q3 2015.
  • AbbVie made up 0.59% of Dinsmore Capital Management's portfolio in Q3 2015, its #79 holding.
  • Dinsmore Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
  • Dinsmore Capital Management's AbbVie position peaked at $1.68M in Q2 2015.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Dinsmore Capital Management's 13F filing for Q3 2015, filed 20 Oct 2015.